User profiles for Howard Chertkow
Howard ChertkowSenior Scientist and Chair of Cognitive Neurology and Innovation, Baycrest Health Sciences … Verified email at research.baycrest.org Cited by 62876 |
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
…, I Collin, JL Cummings, H Chertkow - Journal of the …, 2005 - Wiley Online Library
Objectives: To develop a 10‐minute cognitive screening tool (Montreal Cognitive Assessment,
MoCA) to assist first‐line physicians in detection of mild cognitive impairment (MCI), a …
MoCA) to assist first‐line physicians in detection of mild cognitive impairment (MCI), a …
Mild cognitive impairment
Mild cognitive impairment is a syndrome defined as cognitive decline greater than expected
for an individual's age and education level but that does not interfere notably with activities …
for an individual's age and education level but that does not interfere notably with activities …
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic …
GM McKhann, DS Knopman, H Chertkow… - Alzheimer's & …, 2011 - Elsevier
The National Institute on Aging and the Alzheimer’s Association charged a workgroup with
the task of revising the 1984 criteria for Alzheimer’s disease (AD) dementia. The workgroup …
the task of revising the 1984 criteria for Alzheimer’s disease (AD) dementia. The workgroup …
Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial
…, A Carrasco, JC Yepez, E Chavez, H Chertkow… - Jama, 2023 - jamanetwork.com
Importance There are limited efficacious treatments for Alzheimer disease. Objective To assess
efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid …
efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid …
Semantic memory loss in dementia of Alzheimer's type: What do various measures measure?
H Chertkow, D Bub - Brain, 1990 - academic.oup.com
This paper examines three methodological issues concerning the measurement of semantic
memory impairment in brain-damaged patients. Ten carefully selected patients with …
memory impairment in brain-damaged patients. Ten carefully selected patients with …
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease
Cortical thickness is a more reliable measure of atrophy than volume due to the low variability
in the cytoarchitectural structure of the grey matter. However, this more desirable measure …
in the cytoarchitectural structure of the grey matter. However, this more desirable measure …
Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment.
The goal of the present study was to assess 3 attentional control processes--divided attention,
manipulation capacities, and inhibition--in persons with mild cognitive impairment (MCI) …
manipulation capacities, and inhibition--in persons with mild cognitive impairment (MCI) …
World‐Wide FINGERS Network: a global approach to risk reduction and prevention of dementia
Reducing the risk of dementia can halt the worldwide increase of affected people. The
multifactorial and heterogeneous nature of late‐onset dementia, including Alzheimer's disease (…
multifactorial and heterogeneous nature of late‐onset dementia, including Alzheimer's disease (…
Diagnosis and treatment of dementia: 2. Diagnosis
Background: Dementia can now be accurately diagnosed through clinical evaluation,
cognitive screening, basic laboratory evaluation and structural imaging. A large number of …
cognitive screening, basic laboratory evaluation and structural imaging. A large number of …
Olfaction in patients with mild cognitive impairment and Alzheimer's disease
…, M Jones-Gotman, K De Sousa, H Chertkow - Neurobiology of …, 2008 - Elsevier
Understanding of olfactory dysfunction in Alzheimer's disease (AD) remains limited. In
particular, it is not known how early in the course of the disease olfactory deficits occur, and …
particular, it is not known how early in the course of the disease olfactory deficits occur, and …